Jushi FY22 Revenue Grows 35% To 284.3M, Here Are The Details

Jushi Holdings Inc. JUSHF JUSH released its unaudited preliminary financial results for the Q4 2022 and full year ended December 31, 2022, revealing total revenue of $284.3 million in FY 2022, an increase of 35.8% year-over-year.

Q4 2022 Financial Highlights

  • Total revenue of $76.8 million, an increase of 16.6% year-over-year and 5.5% sequentially

  • Gross profit of $22.0 million, an increase of 11.4% year-over-year

  • Net loss of $139.9 million

  • Adjusted EBITDA of $6.0 million

  • Reduced inventory by $7.0 million versus the prior quarter

  • Cash, cash equivalents and restricted cash were $27.1 million

FY 2022 Financial Highlights

  • Total revenue of $284.3 million, an increase of 35.8% year-over-year

  • Gross profit of $95.5 million, an increase of 14.5% year-over-year

  • Net loss of $202.3 million

  • Adjusted EBITDA of $7.1 million

“Given the challenging macroeconomic backdrop our industry is operating under, I am pleased to report solid annual and quarterly top-line growth,” stated Jim Cacioppo, CEO, chairman and founder of Jushi. “Jushi experienced many bright spots over the course of the year, including rapidly growing our retail network across six markets and diversifying our house of brands and product suite. In addition, we made meaningful progress on the completion of our expansion projects in Pennsylvania and Virginia, were awarded a retail dispensary license establishing our fifth vertically integrated state operation in Ohio, brought on a record number of new Jushi active patients in Virginia’s budding medical market, and scaled our presence in the expanding Nevada market. In 2023, we will continue our focused efforts to realize the full value of the asset base we have built and maximize the return on investment for our shareholders.”

Benzinga's Cannabis Capital Conference Is Back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.

Photo: Benzinga edit with photo by Kindel Media on Pexels

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksMarketsJim Cacioppopremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.


Loading...